Group 1 - The company has approved a profit distribution plan for the fiscal year 2024, which includes a cash dividend of RMB 2.50 per 10 shares, totaling RMB 72 million to be distributed to shareholders [1][2] - The total share capital used for the distribution is 288 million shares, and no bonus shares or capital reserves will be distributed this year [1][2] - The cash dividend will be subject to different tax treatments based on the type of shareholder, with specific rates for Hong Kong investors and domestic investors [2][3] Group 2 - The record date for the distribution is set for May 23, 2025, and the payment will be made on May 26, 2025 [3][4] - The distribution will be directly credited to the shareholders' accounts through their custodial securities companies [3] - The minimum selling price for shares held by certain stakeholders after the distribution will be adjusted to RMB 20.19 per share [4]
亨迪药业: 2024年年度利润分配实施公告